Novartis AG-RegNVSEF
13F holders, Q4 2024 (December 31)2holders
0new positions
1sold out
$97.86avg. 13F price*
At the end of Q4 2024, 2 institutions reported holding Novartis AG-Reg (NVSEF) in their 13F filings, unchanged from Q3 2024. 0 opened new positions and 1 sold out. The largest holders were Boston Common Asset Management, LLC ($17.7M) and Generali Investments CEE, investicni spolecnost, a.s. ($2.4M).
- Company
- Novartis AG-Reg
- CUSIP
- H5820Q150
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $4.7M |
All 13F filers, Q3 2024 → Q4 2024: 46,958 shares sold, net −46,958 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Boston Common Asset Management, LLC | 0.52% | Reduce -3.3% | 181,171 | $17.7M |
| Generali Investments CEE, investicni spolecnost, a.s. | 0.24% | — | 24,200 | $2.4M |
"% of holder's portfolio" is NVSEF's weight in each manager's 13F, not the share of Novartis AG-Reg the manager owns.